Clean Yield Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Clean Yield Group’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$358	Hold	85	–	–	﹤0.01%	388
2026 Q1	$298	Hold	85	–	–	﹤0.01%	378
2025 Q4	$286	Hold	85	–	–	﹤0.01%	402
2025 Q3	$111	Hold	85	–	–	﹤0.01%	412
2025 Q2	$61	Hold	85	–	–	﹤0.01%	399
2025 Q1	$125	Hold	85	–	–	﹤0.01%	436
2024 Q4	$377	Hold	85	–	–	﹤0.01%	449
2024 Q3	$350	Hold	85	–	–	﹤0.01%	465
2024 Q2	$554	Hold	85	–	–	﹤0.01%	356
2024 Q1	$740	Hold	85	–	–	﹤0.01%	373
2023 Q4	$972	Hold	85	–	–	﹤0.01%	356
2023 Q3	$802	Hold	85	–	–	﹤0.01%	364
2023 Q2	$904	Sell	85 -617	-88%	-$6.63K	﹤0.01%	387
2023 Q1	$7.38K	Hold	702	–	–	﹤0.01%	347
2022 Q4	$8.7K	Hold	702	–	–	﹤0.01%	346
2022 Q3	$7K	Hold	702	–	–	﹤0.01%	343
2022 Q2	$8K	Hold	702	–	–	﹤0.01%	353
2022 Q1	$9K	Hold	702	–	–	﹤0.01%	364
2021 Q4	$8K	Hold	702	–	–	﹤0.01%	389
2021 Q3	$9K	Hold	702	–	–	﹤0.01%	386
2021 Q2	$9K	Buy	+702	New	+$8.04K	﹤0.01%	380

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Clean Yield Group's IRWD Position: Q2 2026 in Review

Clean Yield Group held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2026 at 85 shares worth $358. The position accounts for ﹤0.01% of the portfolio, ranked #388.

Clean Yield Group first reported a position in IRWD in Q2 2021 and has held it in 21 quarters since. The position peaked at $9K in Q1 2022. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Clean Yield Group held 85 shares of Ironwood Pharmaceuticals worth $358 as of Q2 2026.
Clean Yield Group left its Ironwood Pharmaceuticals share count unchanged in Q2 2026.
Ironwood Pharmaceuticals made up ﹤0.01% of Clean Yield Group's portfolio in Q2 2026, its #388 holding.
Clean Yield Group first reported a position in Ironwood Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
Clean Yield Group's Ironwood Pharmaceuticals position peaked at $9K in Q1 2022.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Clean Yield Group's 13F filing for Q2 2026, filed 5 Aug 2026.